- Home
- Free App Analytics
- iBOOD.com
- iBOOD.com Vs. Luscii
iBOOD.com vs Luscii Usage & Stats
iBOOD.com: A-brands at the lowest price online!
At iBOOD.com you will only find A-brands with discounts up to 80%. Think of laptops, smart TVs, smartphones, tablets, shoes, designer furniture and the best gadgets! And different deals every day!
With the iBOOD app you will browse and order your deals on your smartphone in a snap. Download it now and make sure you do not miss out!
- Google Play Store
- Free
- Shopping
Store Rank
- -
What is Luscii?
Luscii makes modern care possible. The Luscii app can be prescripted by healthcare organizations and makes it possible to:
- monitor body values / symptoms
- receive targeted education about (dealing with) illness or health risks
- communicate remotely with healthcare providers
How does it work?
- People have to register first. This normally goes through a hospital.
- The app asks to report a number of body values or symptoms every day. These are based on a user-initiated program by health care providers. There is also education in the app and remote contact.
- A medical team is standing behind the app. They assess the answers that users give in the app (supported by the technique of the app). If there is a medical reason for contacting them, they will do so within 24 hours. This can be done by telephone or via a message. Contact via video calling is also possible.
Medical device and data processing
Luscii is a CE marked medical device. Data is processed according to the General Data Protection Regulation (GDPR). The privacy regulations and terms of use can be found at (http://www.luscii.com/). Luscii is based in Utrecht, the Netherlands.
- Google Play Store
- Free
- Medical
Store Rank
- -
iBOOD.com vs. Luscii ranking comparison
Compare iBOOD.com ranking trend in the past 28 days vs. Luscii
Rank
No Data Available
iBOOD.com vs. Luscii ranking by country comparison
Compare iBOOD.com ranking trend in the past 28 days vs. Luscii
Compare to any site with our free trial
iBOOD.com VS.
Luscii
January 3, 2025